Injectable PH1 Therapy Also Effective in Advanced CKD

(MedPage Today) -- Lumasiran (Oxlumo) was both safe and effective in patients with primary hyperoxaluria type 1 (PH1) and advanced kidney disease, according to the phase III ILLUMINATE-C trial.
In the small, single-arm trial of 21 patients with...